Navigation Links
PDL BioPharma to Present at Upcoming Conferences
Date:5/3/2011

INCLINE VILLAGE, Nev., May 3, 2011 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, is scheduled to present at the following upcoming conferences:Tenth Annual JMP Securities Research ConferenceTuesday, May 10, 20112:00 p.m. PDTSan Francisco, CABank of America Merrill Lynch 2011 Health Care ConferenceWednesday, May 11, 20111:00 p.m. PDTLas Vegas, NVThese presentations will be available to interested parties through live and archived audio webcasts. To access the live and subsequently archived webcasts of the presentation, go to the Company's website at http://www.pdl.com and go to "Company Presentations & Events." Please connect to the website at least 15 minutes prior to the events to allow for any software download that may be necessary. The archived webcasts will be available for seven days following each presentation.

About PDL BioPharma PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The Company receives royalties on sales of a number of humanized antibody products marketed by leading pharmaceutical and biotechnology companies today based on patents which expire in late 2014. For more information, please visit www.pdl.com.  

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.


'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
2. New Biopharmaceutical Company to Accelerate Delivery of Vaccines and Protein Therapeutics
3. PDL BioPharma to Announce First Quarter 2011 Financial Results on April 27, 2011
4. Keryx Biopharmaceuticals Announces Commencement of Phase 3 Program of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical
5. PDL BioPharma to Hold Annual Meeting of Stockholders on June 22, 2011
6. Plato BioPharma, Inc. Sponsors Novel Disease Model Award
7. Reportlinker Adds Top 200 Biopharmaceuticals Industry Report (Global)
8. New Survey Emphasizes Value of Biopharmaceutical Company Engagement With Healthcare Providers
9. PRA International Experts to Chair BioPharma Asia Panels
10. Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited
11. Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015 Regen BioPharma, Inc. (OTCBB: ... a novel means of delivering its patented (US ... liver tumors utilizing a clinically approved formulation as ... hurdles with gene silencing therapeutics in which the ... the whole body.  By utilizing a local delivery ...
(Date:8/31/2015)... 2015 BioLight Life ... ("BioLight" or the "Company"), a firm that invests ... and cancer diagnostics, today announced that its cancer ... several new genetic markers with high potential to ... with bisphosphonate drugs and was able to repeat ...
(Date:8/31/2015)... 31, 2015  AMRI (NASDAQ: AMRI ) ... collaboration focused on the development, manufacture and marketing ... ("APIs"). The collaboration combines Saneca,s strength in extracting ... developing and manufacturing controlled substance APIs with AMRI,s ... processes into these facilities. The collaboration will also ...
Breaking Medicine Technology:Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 3AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 4
... April 28, 2011 There,s a sea change sweeping across the ... do they need to carry bottles of liquid and slow-acting pills ... a car, plane or when watching a 3-D movie. ... in the battle against motion-sickness, allowing people to easily avoid nausea ...
... (NYSE: CVS ) today announced it expects ... business of Universal American on Friday, April 29, 2011. ... shareholders cash consideration of $1.25 billion plus the excess ... Part D business, less Universal American,s outstanding trust preferred ...
Cached Medicine Technology:Zentrip Offers a 'Sea Change' in Stopping the Distress from Motion Sickness 2CVS Caremark to Complete Acquisition of Universal American's Medicare Part D Business 2CVS Caremark to Complete Acquisition of Universal American's Medicare Part D Business 3
(Date:8/31/2015)... ... 31, 2015 , ... CareSource, a nonprofit Ohio-based health plan, ... capacity, Michael will provide strategic leadership for CareSource’s marketing, branding, corporate communications and ... have contributed to the company’s rapid growth. As the CareSource business model expands ...
(Date:8/31/2015)... BAY PINES, FL (PRWEB) , ... August 31, 2015 , ... ... accessible, high quality healthcare to Veterans residing across southwest Florida by hiring more doctors ... added to the list of expanded services. , In early July, Dr. Anthony Jabre ...
(Date:8/31/2015)... ... September 01, 2015 , ... ... for traumatic brain injury with emphasis on transcranial near-infrared laser phototherapy ”. , ... Traumatic brain injury has been largely untreatable - with mostly palliative treatments only ...
(Date:8/31/2015)... ... , ... Since 1946, the doctors and staff at Clifton Dental Associates have ... arrives at the office, the staff will make them feel welcome and comfortable. ... create a complete dental treatment plan that is unique to each smile! NJ ...
(Date:8/31/2015)... ... August 31, 2015 , ... With the FCPX LUT Soft pack from Pixel Film Studios, editors ... Table that contains a mathematical formula for modifying an image. The LUT changes every pixel's ... CUBE LUT files. , FCPX LUT Soft requires Final Cut Pro X 10.2 or ...
Breaking Medicine News(10 mins):Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 3Health News:NJ Top Dentists Presents, Clifton Dental Associates! 2Health News:Pixel Film Studios, FCPX Plugin Developer, Releases FCPX LUT Soft 2
... 2011 The children most likely to walk or cycle ... and in an economically disadvantaged home, according to survey results ... Roman Pabayo of the University of Montreal Hospital Research Centre ... study is unique in that it follows the same group ...
... SATURDAY, July 2 (HealthDay News) -- Staying hydrated is critical ... have different hydration needs, so you need to assess your ... of Tennessee at Chattanooga. "Sweat rate is very simple ... as possible; exercise for half an hour and don,t drink ...
... News) -- Nausea and vomiting after waking from general anesthesia ... from 122 patients with severe postoperative nausea and vomiting (PONV) ... initially identified 41 genetic targets (single nucleotide polymorphisms -- SNPs) ... them to at least one SNP that was common to ...
... contain baked milk into the diets of children who have ... according to a study conducted at Mount Sinai School of ... the May 23 issue of the Journal of Allergy ... 2 to 17 years old, who were diagnosed with milk ...
... 1 (HealthDay News) -- Increasing daily soluble fiber intake may ... other substances linked to a host of chronic diseases, according ... found just under the skin, visceral fat is located deep ... Researchers at Wake Forest Baptist Medical Center found the way ...
... 1, 2011 Surgery and all its implications can be ... dread sometimes disfiguring scars. Now a UT Southwestern Medical ... that makes scarring virtually invisible yet is just as effective ... with minimally invasive surgery, leave the child with up to ...
Cached Medicine News:Health News:Urban children are healthier commuters than rural teens 2Health News:How to Stay Hydrated in Hot Weather 2Health News:Foods with baked milk may help build tolerance in children with dairy allergies 2Health News:Soluble Fiber Appears Key to Trimming 'Bad Fat' 2Health News:UT Southwestern pediatric urologist develops procedure to eliminate scarring in kidney surgeries 2
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTC/1Q chairs are recommended for ... clean room, static control, health care ...
... chairs with concave seats and ... • Select options like seats, ... glides. • BTT/1P chairs are ... industry, education, laboratory, clean room, ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With tubular ...
Medicine Products: